Loading data for OGN — first visit, this takes a few seconds.
Organon & Co. (OGN)
NYSE: OGN
· 即時價格 · USD
13.64
+0.01 (0.07%)
收盤價： Sep 11, 2026, 3:59 PM
13.64
+0.00%
盤後: 5:25 PM
股價、關鍵數字和最新消息，都在這一頁。
Organon & Co.（OGN）股價、分析與資料
0.07% (1D)
| 買價 | 13.64 |
| 市值 | 3.58B |
| 營收 (ttm) | 6.13B |
| 淨利（ttm） | 209M |
| 1.52 | |
| 0.78 | |
| 17.49 | |
| 3.77 | |
| P/B (ttm) | 3.56 |
| P/S (ttm) | 0.58 |
| 財報日期 | Nov 9, 2026 |
| 賣價 | 13.65 |
| 成交量 | 1,700,778 |
| 20 日平均成交量 | 2,799,075 |
| 開盤價 | 13.65 |
| 前收盤價 | 13.63 |
| 當日區間 | 13.63 - 13.65 |
| 52 週範圍 | 5.69 - 13.79 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | $0.08 (0.59%) |
| 除息日 | Aug 14, 2026 |
關於 OGN
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; C...
完整的公司簡介財報驚奇
Organon & 已於 Jul 31, 2026 公布季度財報：
- 營收為 $1.56B 低於預期 $0, 年增 -2.26% 下滑.
- 每股盈餘為 0.85 低於預期 -0.22, 年增 -15.00% 下滑.
第 1 頁，共 2 頁